DPT Laboratories, Ltd.

Form 483 issued April 6, 2023 · San Antonio, Texas

Inspection
Apr 3 – Apr 6, 2023
Investigator
Gilbert Valdez
Observations
1
Pages
2
FEI number
1000117684

In short: On April 6, 2023, FDA issued a Form 483 with 1 observation to DPT Laboratories, Ltd. in San Antonio, Texas (FEI 1000117684) after an inspection that ran Apr 3 – Apr 6, 2023. The investigator was Gilbert Valdez. Most observations concern cAPA; the most-cited regulation is 21 CFR 820.100 (corrective and preventive action).

At a glance

1 of 1 observations on this 483 concern capa.

CAPA1

Most cited: 21 CFR 820.100 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Corrective and preventive actions have not been verified or validated to ensure that the action is…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at DPT Laboratories, Ltd.?

FDA listed 1 observation on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 820.100 (corrective and preventive action). The opening words of each observation are shown on this page.

Who inspected DPT Laboratories, Ltd.?

Gilbert Valdez is named on this Form 483, for the inspection of Apr 3 – Apr 6, 2023. Each investigator has a profile showing what they cite most.

When was DPT Laboratories, Ltd. inspected by FDA?

The inspection ran Apr 3 – Apr 6, 2023, and the Form 483 is dated April 6, 2023.

How do I get the full Form 483 for DPT Laboratories, Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free